Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Halo Collective Revenue (TTM): 18.30M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 18.30M |
March 31, 2023 | 21.60M |
December 31, 2022 | 24.54M |
September 30, 2022 | 28.34M |
June 30, 2022 | 31.54M |
March 31, 2022 | 33.80M |
December 31, 2021 | 36.18M |
September 30, 2021 | 32.93M |
June 30, 2021 | 31.02M |
March 31, 2021 | 27.13M |
December 31, 2020 | 21.64M |
September 30, 2020 | 19.25M |
June 30, 2020 | 19.57M |
March 31, 2020 | 23.88M |
December 31, 2019 | 28.15M |
September 30, 2019 | 28.46M |
June 30, 2019 | 24.91M |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 |
Date | Value |
---|---|
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
18.30M
Minimum
Jun 2023
36.18M
Maximum
Dec 2021
26.54M
Average
27.13M
Median
Mar 2021
Revenue (TTM) Benchmarks
CEN Biotech Inc | 1.081M |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 175.51M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.386M |